Disease/Infection News

RSS

Cuba reports 92.4 percent efficacy for 3 dose SOBERANA 02 COVID-19 vaccine

A new study describes the results of the safety and efficacy phase trials of a new COVID-19 vaccine from Cuba.

4 Nov 2021

Clear communication needed with college students regarding COVID-19 vaccine procedures and cost

A new study explores the acceptability and usage of COVID-19 vaccines among the student community.

4 Nov 2021

Automated method shows predictive power for COVID-19 in-hospital mortality

Researchers focussed on the S-learner strategy of estimating the conditional average treatment effect.

4 Nov 2021

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

A team of scientists has recently developed an allele-specific probe polymerase chain reaction method that can accurately detect different variants/lineages of SARS-CoV-2 in respiratory samples.

4 Nov 2021

Murine hepatitis virus as a surrogate for studying SARS-CoV-2 in food processing biofilms

Researchers from Texas A&M University inoculated MHV (SARS-CoV-2 surrogate) into a meat processing environmental biofilm and developed it on stainless steel (SS), PVC, and tiles at 7°C.

4 Nov 2021

Genomic characterization of SARS-CoV-2 gamma variant in Brazil

In this study, researchers describe the full-length SARS-CoV-2 genomes of 44 clinical samples from Amazonas, Brazil.

4 Nov 2021

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Researchers have tried to develop an innovative platform for ultrasensitive and rapid detection of SARS-CoV-2 by exploiting a variation of Raman Spectroscopy.

4 Nov 2021

SARS-CoV-2 detected in white-tailed deer with possible zooanthroponotic spillover events

The study aimed to test the hypothesis that the infection and transmission of SARS-CoV-2 of deer occurred in nature.

4 Nov 2021

Novel model-based framework evaluates immune mechanism of COVID-19 vaccine response

A model framework for characterizing viral dynamics and vaccine efficacy in non-human primates is described and applied to the identification of correlates of protection in three independent vaccine studies.

4 Nov 2021

Identification of novel SARS-CoV-2 alpha variant sub-lineage in Europe

Scientists from Germany have recently identified a new sub-lineage of the alpha variant of SARS-CoV-2 in some European countries.

4 Nov 2021

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Now, a new study published on the medRxiv* preprint server tests the hypothesis that adverse COVID-19 outcomes are associated with the variants of the APOL1 gene.

4 Nov 2021

Cas13 shines a light on SARS-CoV-2 variants

Now, a new study published on the medRxiv* preprint server describes and benchmarks SHINEv2, a Cas13-based nucleic acid diagnostic for SARS-CoV-2 detection. SHINEv2 combines temperature sample processing and lyophilized reagents to simplify the test procedure and assay distribution immensely.

4 Nov 2021

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

The study, recently published in The Journal of the American Medical Association, deduced that previous SARS-CoV-2 infection is associated with a statistically significant reduced hazard of breakthrough infection among recipients of both the BNT162b2 (Pfizer-BioNTech) and the mRNA-1273 (Moderna) vaccines.

3 Nov 2021

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

Malaria, a pathogen transmitted into blood by mosquitoes in tropical climates, is typically thought of as a blood and liver infection.

3 Nov 2021

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

A comprehensive characterization of the immune responses between SARS-CoV-2 infected individuals with wildtype (WT) and Δ382 SARS-CoV-2.

3 Nov 2021

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Researchers evaluate the safety and immunogenicity of an influenza vaccine and mRNA-based COVID-19 vaccine that were administered concomitantly.

3 Nov 2021

Cross-reactive immunity against coronaviruses

Researchers review the heterologous immunity to coronaviruses and the extent of immune cross-reactivity against SARS-CoV-2.

3 Nov 2021

Pre-clinical follow-up study boosting with original formulation and next generation INO-4802 SARS-CoV-2 vaccine candidate

Researchers describe the antibody-inducing effects of DNA-based synthetic vaccines INO-4800 and INO-4802 against SARS-CoV-2 in non-human primates.

3 Nov 2021

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

German scientists used DNA nanolevers to target the interaction between a peptide known as PeB and influenza A.

3 Nov 2021

Spike antibody durability in mRNA vaccinated individuals with or without prior SARS-CoV-2 infection

A new study examined SARS-CoV-2 spike IgG antibodies in a longitudinal cohort, comparing antibody durability in individuals who received an mRNA SARS-CoV-2 vaccine with or without prior SARS-CoV-2 infection.

3 Nov 2021

Disease/Infection News

Cuba reports 92.4 percent efficacy for 3 dose SOBERANA 02 COVID-19 vaccine

Clear communication needed with college students regarding COVID-19 vaccine procedures and cost

Automated method shows predictive power for COVID-19 in-hospital mortality

Highly-sensitive PCR-based method to detect SARS-CoV-2 variants

Murine hepatitis virus as a surrogate for studying SARS-CoV-2 in food processing biofilms

Genomic characterization of SARS-CoV-2 gamma variant in Brazil

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

SARS-CoV-2 detected in white-tailed deer with possible zooanthroponotic spillover events

Novel model-based framework evaluates immune mechanism of COVID-19 vaccine response

Identification of novel SARS-CoV-2 alpha variant sub-lineage in Europe

APOL1 variant risk may extend to poorer outcomes from SARS-CoV-2 infection

Cas13 shines a light on SARS-CoV-2 variants

Prior SARS-CoV-2 infection and risk of breakthrough infection following mRNA vaccination

Unexpected antibody discovery provides new insight into how the body responds to malaria infection

Adaptive immunity in patients infected with SARS-CoV-2 Δ382 Variant

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Cross-reactive immunity against coronaviruses

Pre-clinical follow-up study boosting with original formulation and next generation INO-4802 SARS-CoV-2 vaccine candidate

Studying influenza A virus and peptide interactions with electrically controllable DNA nanoconstructs

Spike antibody durability in mRNA vaccinated individuals with or without prior SARS-CoV-2 infection

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News